Lower risk Drug recall · FDA · Published August 30, 2024

Glenmark Mupirocin Ointment 2% Recall: Subpotent Drug Risk

Glenmark Pharmaceuticals recalls 2% mupirocin ointment (22g) due to subpotent drug levels. Rx only product with specific lot numbers and expiration dates. Consumers should check their product details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0660-2024Drug Glenmark ›

Lower-risk recall

Subpotent Drug

Take action

Contact the company

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009

✎ GovInfoNow plain-language explainer

Glenmark Pharmaceuticals is recalling mupirocin ointment 2% (22g) because it may contain lower-than-stated drug levels. This could lead to treatment being less effective for infections. The product is prescription-only and must be checked for specific lot numbers. Read more at govinfonow.com/recall/32550-glenmark-mupirocin-ointment-2-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32550-glenmark-mupirocin-ointment-2-recall-subpotent-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0660-2024

Cite this page

“Glenmark Mupirocin Ointment 2% Recall: Subpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32550-glenmark-mupirocin-ointment-2-recall-subpotent-drug-risk. Based on FDA recall #D-0660-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0660-2024%22&limit=1).

The FDA announced on Aug. 30, 2024, that Glenmark Pharmaceuticals Inc., USA is recalling Mupirocin Ointment, USP, 2%, due to subpotent drug risks. The agency issued recall number D-0660-2024 for the voluntary Class II action.

How to tell if you have it

Brand: Glenmark
Product: Mupirocin Ointment, USP, 2%, 22 g
NDC: 68462-180-22
Lot codes: 19223615, 19223537, 19223544, 19223568, 19223593, 19223641 (Exp. 08/2024); 19224055, 19224281, 19224307, 19224321, 19224341, 19224467 (Exp. 09/2024); 19224525, 19224542, 19224560, 19224580 (Exp. 10/2024); 19224990, 19224998, 19225014, 19225033, 19225293, 19225304, 19225320, 19225349, 19225367, 19225379, 19225401 (Exp. 11/2024); 19230115, 19230123, 19230132, 19230137, 19230167, 19230170 (Exp. 12/2024); 19230572, 19230607, 19230614, 19230628, 19230631 (Exp. 1/2025); 19230874, 19230925, 19230941, 19230957, 19230976, 19231232, 19231238, 19231282, 19231285 (Exp. 02/2025)
Quantity: 2,031,480 units
Distribution: Nationwide within the United States

The hazard

The recall addresses subpotent drug risks associated with the Mupirocin Ointment. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has 54 other recalls on record since 2017-11-20. Recent brand recalls include the 2026-07-23 Glenmark Azelaic Acid Gel recall for grainy texture risk, the 2026-05-27 Alyacen Birth Control Tablets recall for impurities risk, and the 2025-12-30 Ondansetron Tablets recall for blister packs not fully sealed. Other recent recalls of similar products include Somerset Therapeutics Cisatracurium Besylate Injection (2025-11-26), Unichem busPIRone 5mg Tablets (2026-04-13), and Gasco Isopropyl Alcohol 70% (2026-05-29).

How to tell if you have this one

Check the product label for the lot numbers listed: 19223615, 19223537, 19223544, 19223568, 19223593, 19223641 (exp. 08/2024), and other specific lot numbers with corresponding expiration dates.

Brand
Glenmark
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for the lot numbers listed in the recall notice: 19223615, 19223537, 19223544, 19223568, 19223593, 19223641, and other specific lot numbers with corresponding expiration dates.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Product was distributed nationwide within the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 33 days after the firm started it.

Aug 30, 2024Firm started the recall
Sep 20, 2024FDA classified it Class II
Oct 2, 2024Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Glenmark recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32550-glenmark-mupirocin-ointment-2-recall-subpotent-drug-risk">Glenmark Mupirocin Ointment 2% Recall: Subpotent Drug Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0660-2024 (August 30, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0660-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.